DHL promises life sciences focus

Logistics provider DHL has announced improved service offerings during its annual life sciences and healthcare conference in Miami. Identifying life sciences as a key focus sector, DHL Global Forwarding and Freight CEO Hermann Ude discussed strengthening cross-divisional collaboration to provide simplified and sustainable customer solutions, according to an announcement.

"Because of unique safety and regulatory requirements, the transportation and logistics needs require particularly rigorous levels of quality and competence in product handling. At the same time, the industry is increasingly turning to strategic partners for innovative solutions to support supply chain operations," he concluded.

Such collaborations as the one announced early this year between pharma giant Merck and UPS Healthcare Logistics is one example. In that deal, UPS took over two of Merck's cGMP distribution centers, comprising some 200,000 square feet, relieving the drug maker of fixed assets and freeing resources for core strategic concerns.

The DHL move also acknowledges a pharmaceutical manufacturing trend of shortening the list of logistics service providers and asking more of those who remain involved. The company says it can review a customer's supply chain and identify key performance indicators and pain points to create tailored logistics services.

- read the announcement

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.